Benjamin Carroll, PharmD

Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

BACKGROUND: Antipsychotics are commonly used for maintenance treatment of schizophrenia (SZ), bipolar disorder (BP), and major depressive disorder (MDD). Treatment adherence reduces the r...

Benjamin Carroll , PharmD;

Fan Mu , PhD;

Darren Thomason , MBA;

Michael Philbin , MSc, PharmD, MBA;

Rajeev Ayyagari , PhD;

11/22/2019

An Experimental Study to Assess the Professional and Social Consequences of Mild-to-Moderate Tardive Dyskinesia

BACKGROUND: Tardive dyskinesia (TD), a movement disorder, may arise in patients taking antipsychotics. Social and professional stigma associated with mild-to-moderate TD movements has not...

Stanley Caroff , MD;

Benjamin Carroll , PharmD;

Debbie Goldschmidt , PhD;

Fan Mu , PhD;

Michael J. Crescenz ;

Rajeev Ayyagari , PhD;

11/22/2019

Effect of Tardive Dyskinesia on Quality of Life: Patient-Reported Symptom Severity Is Associated With Physical, Mental, and Social Functioning Deficits

Background: Tardive dyskinesia (TD), an often-irreversible movement disorder typically caused by exposure to antipsychotics, most commonly affects the face, mouth, and tongue, and may be ...

Avery Rizio , PhD;

Jakob Bjorner , MD, PhD;

Stephen Maher , PhD;

Mark Kosinski , DPM, FIDSA, MA;

Sanjay K. Gandhi , MD, PhD;

Joseph McEvoy , MD;

Benjamin Carroll , PharmD;

03/01/2019